Literature DB >> 18981100

The host environment regulates the function of CD8+ graft-versus-host-reactive effector cells.

Ronjon Chakraverty1, Barry Flutter, Farnaz Fallah-Arani, Hyeon-Seok Eom, Terry Means, Giovanna Andreola, Sebastian Schwarte, Jennifer Buchli, Pete Cotter, Guiling Zhao, Megan Sykes.   

Abstract

We have examined how the host environment influences the graft-vs-leukemia (GVL) response following transfer of donor T cells to allogeneic chimeras. Donor T cells induce significant GVL when administered in large numbers to established mixed chimeras (MC). However, when using limiting numbers of T cells, we found that late transfer to MC induced less GVL than did early transfer to freshly irradiated allogeneic recipients. Late donor T cell transfer to MC was associated with marked accumulation of anti-host CD8 cells within the spleen, but delayed kinetics of differentiation, reduced expression of effector molecules including IFN-gamma, impaired cytotoxicity, and higher rates of sustained apoptosis. Furthermore, in contrast to the spleen, we observed a significant delay in donor CD8 cell recruitment to the bone marrow, a key location for hematopoietic tumors. Increasing the numbers of T cells transferred to MC led to the enhancement of CTL activity and detectable increases in absolute numbers of IFN-gamma(+) cells without inducing graft-vs-host disease (GVHD). TLR-induced systemic inflammation accelerated differentiation of functional CTL in MC but was associated with severe GVHD. In the absence of inflammation, both recipient T and non-T cell populations impeded the full development of GVHD-inducing effector function. We conclude that per-cell deficits in the function of donor CD8 cells activated in MC may be overcome by transferring larger numbers of T cells without inducing GVHD.

Entities:  

Mesh:

Year:  2008        PMID: 18981100     DOI: 10.4049/jimmunol.181.10.6820

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

Review 1.  Emerging concepts in haematopoietic cell transplantation.

Authors:  Hao Wei Li; Megan Sykes
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

2.  Variations in mRNA and protein levels of Ikaros family members in pediatric T cell acute lymphoblastic leukemia.

Authors:  Julie L Mitchell; Thomas M Yankee
Journal:  Ann Transl Med       Date:  2016-10

3.  TLR-Induced Murine Dendritic Cell (DC) Activation Requires DC-Intrinsic Complement.

Authors:  Joong-Hyuk Sheen; Michael G Strainic; Jinbo Liu; Weijia Zhang; Zhengzi Yi; M Edward Medof; Peter S Heeger
Journal:  J Immunol       Date:  2017-05-24       Impact factor: 5.422

4.  IFN-γ and indoleamine 2,3-dioxygenase signaling between donor dendritic cells and T cells regulates graft versus host and graft versus leukemia activity.

Authors:  Ying Lu; Cynthia R Giver; Akshay Sharma; Jian Ming Li; Katarzyna A Darlak; Lauren M Owens; John D Roback; Jacques Galipeau; Edmund K Waller
Journal:  Blood       Date:  2011-11-30       Impact factor: 22.113

Review 5.  Immune monitoring of transplant patients in transient mixed chimerism tolerance trials.

Authors:  Megan Sykes
Journal:  Hum Immunol       Date:  2017-12-28       Impact factor: 2.850

6.  Persistent sacral chloroma in refractory acute myelogenous leukaemia.

Authors:  Scott Mathew McCarty; Dennis John Kuo
Journal:  BMJ Case Rep       Date:  2017-07-06

Review 7.  Separating graft-versus-leukemia from graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

Authors:  Jian-Ming Li; Cynthia R Giver; Ying Lu; Mohammad S Hossain; Mojtaba Akhtari; Edmund K Waller
Journal:  Immunotherapy       Date:  2009-07       Impact factor: 4.196

8.  SHP-1 Acts as a Key Regulator of Alloresponses by Modulating LFA-1-Mediated Adhesion in Primary Murine T Cells.

Authors:  Martin G Sauer; Jessica Herbst; Ulf Diekmann; Christopher E Rudd; Christian Kardinal
Journal:  Mol Cell Biol       Date:  2016-11-28       Impact factor: 4.272

9.  Recipient NK cell inactivation and intestinal barrier loss are required for MHC-matched graft-versus-host disease.

Authors:  Sam C Nalle; H Aimee Kwak; Karen L Edelblum; Nora E Joseph; Gurminder Singh; Galina F Khramtsova; Eric D Mortenson; Peter A Savage; Jerrold R Turner
Journal:  Sci Transl Med       Date:  2014-07-02       Impact factor: 17.956

10.  Complete response of myeloid sarcoma with cardiac involvement to radiotherapy.

Authors:  Wen-Chi Yang; Ming Yao; Yu-Hsuan Chen; Sung-Hsin Kuo
Journal:  J Thorac Dis       Date:  2016-06       Impact factor: 2.895

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.